Kolexia
Arnould Laurent Anatomie et cytologie
Arnould Laurent
Anatomie et cytologie
Centre Georges-François Leclerc
Dijon, France
172 Activités
221 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinomes Carcinome canalaire du sein Récidive tumorale locale Métastase lymphatique Tumeurs de l'ovaire Tumeurs du poumon Métastase tumorale Tumeurs du sein triple-négatives

Collaborateurs

Voir plus
Ladoire Sylvain
Ladoire Sylvain
Centre Georges-François Leclerc, Dijon, France
Ghiringhelli Francois
Ghiringhelli Francois
Centre Georges-François Leclerc, Dijon, France
Coudert Bruno
Coudert Bruno
Centre Georges-François Leclerc, Dijon, France
Derangere Valentin
Derangere Valentin
Centre Georges-François Leclerc, Dijon, France

Industries

Voir plus
AstraZeneca
24 collaboration(s)
Dernière en 2023
Roche
10 collaboration(s)
Dernière en 2023
MSD
9 collaboration(s)
Dernière en 2023
Daiichi Sankyo
5 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Bias reduction using combined stain normalization and augmentation for AI-based classification of histological images.
Computers in biology and medicine   08 février 2024
Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy.
Frontiers in oncology   10 janvier 2024
Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours.
Bulletin du cancer   06 octobre 2023
PADA-1: Randomized, Open Label, Multicentric Phase III Trial to Evaluate the Safety and Efficacy of Palbociclib in Combination With HT Driven by ctDNA ESR1 Mutation Monitoring in ER+, HER2-negative Metastatic Breast Cancer Patients
Essai Clinique (Pfizer)   21 septembre 2023
Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Breast cancer (Tokyo, Japan)   10 août 2023
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.
Molecular cancer   29 juillet 2023
Evaluation of the management of intracystic papillary carcinoma.
Bulletin du cancer   11 mai 2023
Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas.
Cancer research communications   10 mai 2023
Input of PRS313 for breast cancer risk stratification in patients with atypical breast lesion
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference   01 mai 2023
Anticipating changes in the HER2 status of breast tumours with disease progression-towards better treatment decisions in the new era of HER2-low breast cancers.
British journal of cancer   29 avril 2023